UK-based creative leader joins global organisation for life science sales and marketing professionals

SAMPS — the US-based global professional network for sales and marketing professionals in science — has announced the appointment of David Lister, CEO of UK-based life science creative agency CLOK, to its Board of Directors.

David’s appointment reflects SAMPS’s commitment to expanding its global reach and fostering innovation in how science is communicated and commercialised. Based in the UK, David brings over 20 years of experience helping life science companies clarify complex ideas and accelerate commercial success through high-impact digital content.

As founder and CEO of CLOK, David leads a multidisciplinary team that blends strategy, design, animation, and interactivity to support biotech, medtech, and pharmaceutical brands. His career spans agency leadership, large-scale pharma campaigns, and the development of interactive tools designed to empower scientific sales teams.

“Sales and marketing in life sciences is evolving fast — and SAMPS is at the centre of that transformation,” said David Lister. “I’m excited to contribute a creative and strategic perspective as the organisation continues to grow globally.”

A former Account Director for major pharmaceutical campaigns and a long-standing entrepreneur, David brings a unique combination of creative vision and industry know-how to the SAMPS boardroom.


About SAMPS
SAMPS (Sales and Marketing Professionals in Science) is the only global organisation dedicated to connecting and supporting commercial leaders in the life sciences. Through community, content, and peer-driven events, SAMPS empowers its members to share ideas, sharpen strategies, and shape the future of scientific commerce.

About David Lister
David Lister is the founder and CEO of CLOK, a UK-based creative agency that helps life science companies transform complex science into clear, compelling content. With more than two decades of experience leading strategy, design, and interactive storytelling for biotech and medtech brands, David brings a deep understanding of how clarity drives commercial growth.